22 April 2021 - Deborah Wilkes
Switzerland’s Zur Rose Group said its sales in the first quarter of 2021 had risen by 16.0% in local currency terms as the number of active customers rose by 0.6 million.
The online pharmacy that owns DocMorris recorded sales of CHF503 million (USD549 million) in the first quarter of 2021. This represented a rise of 16.0% in local currencies and 17.8% as reported compared to the same period a year earlier.
Zur Rose said the “dynamic revenue development” had been achieved despite a drop in demand for cold and flu remedies that had been caused by social distancing measures to control the COVID-19 pandemic.
Growth had been boosted, the company said, by the trend towards online purchases and the continued positive trend in new clients.
Zur Rose said it had 11.1 million active customers as of 31 March 2021, representing an increase of 0.6 million compared to 31 December 2020.
Sales climb in Germany
Sales at Zur Rose’s German business increased by 25.2% in local currency terms to CHF337 million in the first quarter of 2021. The rise as reported was 27.9%.
Zur Rose said growth had been driven by the non-prescription drugs business as well as beauty and personal care products.
The company announced in June 2020 that it had strengthened its presence in Germany by acquiring the online pharmacy Apotal (click here to read the News story).
Performance in Switzerland
Sales at Zur Rose's Swiss business fell by 2.8% to CHF147 million. Zur Rose noted that the comparison was with strong growth of 16.1% in the same period a year earlier.
Sales by the Rest of Europe business, which covers Zur Rose’s marketplaces in Spain and France, increased by 57.6% in local currency terms to CHF19.9 million. Sales as reported were up by 61.1%.
The company said the performance reaffirmed the “attractive growth potential of the marketplace business in the longer term”.
Zur Rose is in the process of transforming itself from a pure mail-order pharmacy into a European healthcare ecosystem using DocMorris as an umbrella brand (click here to read the News story).